• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Healthcare Law's Impact on Businesses Varies

Article

Companies specializing in driving down spending on health care, whether through electronic records, preventive care or consolidating services, are turning out to be the biggest winners from the 2010 health care law.

Investors, analysts and policymakers say any business that can help health care providers cut costs or keep patients from being readmitted to the hospital soon after an in-patient visit is attracting more customers and seeing more investment.

Read the full story: http://usat.ly/PZgqBu

Source: USA Today

Related Videos
Dr Amrita Basu
Eleanor Perfetto, PhD
Steven Manobianco, MD
Dr Amrita Basu
Justin Drake, PhD
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Ciara Zachary, PhD, MPH
Related Content
Carlos Doti, MD | Image: AstraZeneca

‘Our Responsibility Should Be to Give You the Closest Thing to a Normal Life’

January 2nd 2026
Article

Read More

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA

January 1st 2026
Podcast

Sachin H. Jain, MD, MBA, discusses 2026 health care predictions, including AI adoption, GLP-1 demand, MAHA growth, DEI’s return, and policy shifts.

Listen

The top 5 cardiovascular content of 2025

Top 5 Most-Read Cardiovascular Content of 2025

December 30th 2025
Article

New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

The Top 5 Gated Content of 2025

Top 5 Gated Content for 2025

December 29th 2025
Article

Explore the evolving landscape of drug pricing, reproductive rights, and health policy in 2025, featuring insights on SC pembrolizumab and RFK Jr's hearings.

Read More

The top 5 reimbursement content of 2025

Top 5 Most-Read Reimbursement Content of 2025

December 28th 2025
Article

The most-viewed content focused on the “One Big Beautiful Bill,” the Most Favored Nation drug policy, and other changes under the Trump administration.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.